(R)-(+)-Nor Verapamil Hydrochloride - CAS 123932-43-4
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
(R)-(+)-Nor Verapamil Hydrochloride
Catalog Number:
123932-43-4
Synonyms:
(αR)-α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-benzeneacetonitrile Hydrochloride; (R)-Norverapamil Hydrochloride;
CAS Number:
123932-43-4
Description:
This active molecular is a chiral metabolite of Verapamil which is a calcium channel blocker applicated in the treatment of hypertension, angina pectoris, cardiac arrhythmia, and cluster headaches recently.
Molecular Weight:
447.04
Molecular Formula:
C₂₆H₃₇ClN₂O₄
Quantity:
Milligrams-Grams
Quality Standard:
In-house standard
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
CC(C)C(CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl
InChI:
InChI=1S/C26H36N2O4.ClH/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5;/h8-11,16-17,19,28H,7,12-15H2,1-6H3;1H/t26-;/m1./s1
InChIKey:
OEAFTRIDBHSJDC-UFTMZEDQSA-N
Targets:
Calcium Channel
Chemical Structure
CAS 123932-43-4 (R)-(+)-Nor Verapamil Hydrochloride

Related Calcium Channel Products


Ca2+ Channel Agonist 1
(CAS: 1402821-24-2)

A Ca2+ Channel Agonist that selectively acting on N-type Ca2+ channel and also be found to restrain the cdk activity at some extent. IC50: 14.23 uM (EC50, Ca2+ ...

CAS 111470-99-6 Amlodipine Besylate

Amlodipine Besylate
(CAS: 111470-99-6)

Amlodipine Besylate is a long-acting calcium channel blocker, used to lower blood pressure and prevent chest pain.

CAS 111011-76-8 Efonidipine hydrochloride monoethanolate

Efonidipine hydrochloride monoethanolate
(CAS: 111011-76-8)

The hydrochloride monoethanolate salt form of Efonidipine which has been launched for hypertension and discontinued for cerebrovascular disorders.

CAS 77-67-8 Ethosuximide

Ethosuximide
(CAS: 77-67-8)

Ethosuximide is a Calcium channel antagonist originated by Pfizer. It can be used for the treatment of Absence epilepsy and absence seizures. It may be used by ...

CI 951
(CAS: 126661-07-2)

CI 951 is a dihydronaphthyridine Ca2+ channel antagonist and it may be applicated for the treatment of focal cerebral ischemia. CI 951 has potential as a cerebr...

CAS 1228182-46-4 Chlorpromazine-d6 Hydrochloride

Chlorpromazine-d6 Hydrochloride
(CAS: 1228182-46-4)

Labelled Chlorpromazine. Used as an antiemetic and antipsychotic.

CAS 132866-11-6 Lercanidipine Hydrochloride

Lercanidipine Hydrochloride
(CAS: 132866-11-6)

The hydrochloride salt form of Lercanidipine, a dihydropyridine derivative, could be used as an antihypertensive agent through influencing the L-type Ca2+ chann...

CAS 42399-41-7 Diltiazem

Diltiazem
(CAS: 42399-41-7)

Diltiazem is a nondihydropyridines (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia as a p...

Evenamide
(CAS: 1092977-61-1)

Evenamide is a selective voltage-gated sodium and​/or calcium channel modulator, including subtypes Nav1.3, Nav1.7, and Nav1.8. It may be potentia useful in pre...

CAS 74764-40-2 Bepridil hydroChloride

Bepridil hydroChloride
(CAS: 74764-40-2)

Bepridil is an amine Calcium channel antagonist that used to treat angina. But it is no longer sold in the United States. It may be a possible option in the tre...

CAS 212778-82-0 Elpetrigine

Elpetrigine
(CAS: 212778-82-0)

Elpetrigine, also known as GW 273293 and JZP-4, has a blocking effect on calcium channels and potassium channels which has been in clinical bipolar disorders an...

CAS 75695-93-1 Isradipine

Isradipine
(CAS: 75695-93-1)

Isradipine is a potent and selective L-type voltage-gated calcium channel blocker, used to treat high blood pressure.

CAS 63-91-2 L-phenylalanine

L-phenylalanine
(CAS: 63-91-2)

L-Phenylalanine, a α-amino acid, is an antagonist at α2δ calcium channels (Ki =980 nM).

CAS 357400-13-6 NNC 55-0396 dihydrochloride

NNC 55-0396 dihydrochloride
(CAS: 357400-13-6)

NNC 55-0396 is a derivative of Mibefradil as a T-type calcium channel blocker (IC50=6.8 nM)

CAS 136-47-0 Tetracaine Hydrochloride

Tetracaine Hydrochloride
(CAS: 136-47-0)

Tetracaine hydrochlorideis a hydrochloride salt form of tetracaine which is a potent local anaesthetic and a channel function allosteric inhibitor.

CAS 111011-53-1 EFONIDIPINE HCL

EFONIDIPINE HCL
(CAS: 111011-53-1)

The hydrochloride salt form of Efonidipine which could be effective in the treatment of cardiovascular disease as a blocker of T-type and L-type calcium channel...

CAS 33286-22-5 Diltiazem Hydrochloride

Diltiazem Hydrochloride
(CAS: 33286-22-5)

Diltiazem HCl (Tiazac) is a benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions.

S(-)-BAY K 8644
(CAS: 98625-26-4)

S(-)-BAY K 8644 is an activator of voltage-sensitive L-type calcium channels with positive inotropic, vasoconstrictive and behavioral effects in vivo. It is the...

CAS 128229-52-7 TAMOLARIZINE

TAMOLARIZINE
(CAS: 128229-52-7)

Tamolarizin is a calcium antagonist originated by Nippon Chemiphar. Tamolarizin can induce the increase of GABA in the cerebellum and medulla oblongata followin...

CAS 54527-84-3 Nicardipine Hydrochloride

Nicardipine Hydrochloride
(CAS: 54527-84-3)

Nicardipine is a dihydropyridine calcium-channel blocking agent used for the treatment of vascular disorders.

Reference Reading


1.Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.
Wyles SP1,2, Hrstka SC3,4, Reyes S3,4, Terzic A2,3,5,6, Olson TM5,7,8, Nelson TJ1,2,4,5,9. Clin Transl Sci. 2016 Apr 22. doi: 10.1111/cts.12393. [Epub ahead of print]
For inherited cardiomyopathies, abnormal sensitivity to intracellular calcium (Ca2+ ), incurred from genetic mutations, initiates subsequent molecular events leading to pathological remodeling. Here, we characterized the effect of β-adrenergic stress in familial dilated cardiomyopathy (DCM) using human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CMs) from a patient with RBM20 DCM. Our findings suggest that β-adrenergic stimulation accelerated defective Ca2+ homeostasis, apoptotic changes, and sarcomeric disarray in familial DCM hiPSC-CMs. Furthermore, pharmacological modulation of abnormal Ca2+ handling by pretreatment with β-blocker, carvedilol, or Ca2+ -channel blocker, verapamil, significantly decreased the area under curve, reduced percentage of disorganized cells, and decreased terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL)-positive apoptotic loci in familial DCM hiPSC-CMs after β-adrenergic stimulation.
2.An improved substrate cocktail for assessing direct inhibition and time-dependent inhibition of multiple cytochrome P450s.
Chen ZH1,2, Zhang SX3, Long N3, Lin LS3, Chen T3, Zhang FP3, Lv XQ3, Ye PZ3, Li N4, Zhang KZ3. Acta Pharmacol Sin. 2016 Apr 11. doi: 10.1038/aps.2016.10. [Epub ahead of print]
AIM: The substrate cocktail is frequently used to evaluate cytochrome P450 (CYP) enzyme-mediated drug interactions and potential interactions among the probe substrates. Here, we re-optimized the substrate cocktail method to increase the reliability and accuracy of screening for candidate compounds and expanded the method from a direct CYP inhibition assay to a time-dependent inhibition (TDI) assay.
3.Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
Hattangady NG1, Karashima S2, Yuan L3, Ponce-Balbuena D4, Jalife J5, Gomez-Sanchez CE6, Auchus R7, Rainey WE8, Else T9. J Mol Endocrinol. 2016 Apr 20. pii: JME-15-0324. [Epub ahead of print]
Somatic and germline mutations in the inward rectifying K+channel (KCNJ5) are a common cause of primary aldosteronism (PA) in aldosterone producing adenoma and familial hyperaldosteronism type III, respectively. Dysregulation of adrenal cell calcium signaling represents one mechanism for mutated KCNJ5 stimulation of aldosterone synthase (CYP11B2) expression and aldosterone production. However, the mechanisms stimulating acute and chronic production of aldosterone by mutantKCNJ5have not been fully characterized. Herein, we defined the effects of the T158A KCNJ5 mutation (KCNJ5T158A) on acute and chronic regulation of aldosterone production using an adrenal cell line with a doxycycline inducibleKCNJ5T158Agene (HAC15-TRE-KCNJ5T158A). Doxycycline incubation caused a time-dependent increase inKCNJ5T158AandCYP11B2mRNA and protein levels. Electrophysiological analyses confirm the loss of inward rectification and increased Na+permeability inKCNJ5T158A-expressing cells.
4.Calcium channel blockers ameliorate iron overload-associated hepatic fibrosis by altering iron transport and stellate cell apoptosis.
Zhang Y1, Zhao X2, Chang Y3, Zhang Y4, Chu X5, Zhang X4, Liu Z6, Guo H6, Wang N7, Gao Y4, Zhang J8, Chu L9. Toxicol Appl Pharmacol. 2016 Apr 16. pii: S0041-008X(16)30074-6. doi: 10.1016/j.taap.2016.04.008. [Epub ahead of print]
Liver fibrosis is the principal cause of morbidity and mortality in patients with iron overload. Calcium channel blockers (CCBs) can antagonize divalent cation entry into renal and myocardial cells and inhibit fibrogenic gene expression. We investigated the potential of CCBs to resolve iron overload-associated hepatic fibrosis. Kunming mice were assigned to nine groups (n=8 per group): control, iron overload, deferoxamine, high and low dose verapamil, high and low dose nimodipine, and high and low dose diltiazem. Iron deposition and hepatic fibrosis were measured in mouse livers. Expression levels of molecules associated with transmembrane iron transport were determined by molecular biology approaches. In vitro HSC-T6 cells were randomized into nine groups (the same groups as the mice). Changes in proliferation, apoptosis, and metalloproteinase expression in cells were detected to assess the anti-fibrotic effects of CCBs during iron overload conditions.